Immunohistochemically, the expression of CCL2+ cells and CXCL10+ cells in tumor and peri-tumor were higher than in normal brain tissues, and celecoxib decreased the number of these cells (Fig. 2d). The gene discussed is CCL2; the disease is neoplasm.